Treatment

CSIRO designs new pharmaceutical products, advanced materials such as polymers and fabrics for injuries and uses computer-based technologies to improve treatment outcomes.

CSIRO Plant Industry conducts research to promote profitable and sustainable agrifood, fibre and horticultural industries, develop new plant products and improve natural resource management.

The CSIRO Food Futures Flagship has developed an automated instrument for accurately predicting glycemic index (GI) and resistant starch (RS) in food products.

AusBiotech will hold its 2008 conference, Building a Bioeconomy - climate, food, health, investment, fuel at the Melbourne Convention Centre 26 – 29 October 2008.

The inaugural Australian Crystallisation course will be held at Melbourne University with lectures at Bio 21 between the 8-12 December 2008.

The goal of CSIRO’s Medical Imaging for Early Disease Detection research theme is to improve health and wellbeing by reducing the impact of diseases.

New sophisticated polymer platforms for the improved delivery of small-molecule and biological therapeutics.

Researchers are analysing components that make up certain foods to determine precisely what chemical and physical effects they have when eaten. With CSIRO's expertise we will be able to tailor our diets for better health and to avoid some diseases.

Working with internal and external partners in bioactive discovery for the pharmaceutical, biotechnology, animal health, crop protection and specialty chemical industries.

A CSIRO team - led by Dr Linfa Wang - has played a key role in uncovering a new reovirus that can cause a respiratory tract illness in humans. In this video, Dr Wang explains the significance of the discovery to CSIRO Communication Advisor, Ms Emma Wilkins. (6:00)

The goals and research of the Preventative Health Flagship and how the Preventative Health Flagship is developing preventative strategies to help fight chronic disease are introduced in this video. (6:00)

Dr Megan Fisher is acting Chief of CSIRO Molecular and Health Technologies, she has tertiary qualifications in science and business and an outstanding track record in strategic management, business development and technology commercialisation.

CSIRO Black Mountain laboratories in Canberra have facilities servicing insect, plant, atmospheric, land and water science.

A list of RAFT (reverse addition fragmentation chain transfer) patents, their backgrounds, advantages of the invention and application areas. (7 pages)

A two page brochure featuring case studies of successful partnerships between Australian businesses and the CSIRO ICT Centre.

CSIRO’s IP is a platform technology for the rapid expansion of cells whilst maintaining phenotype. The technology will be useful for a wide range of cellular therapies and tissue engineering applications. (2 pages)